MENU

DMAC DiaMedica Therapeutics Forecast, Technical & Fundamental Analysis

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology
DMAC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
DMAC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

DMAC is expected to report earnings to rise 12.32% to -21 cents per share on November 18

DiaMedica Therapeutics DMAC Stock Earnings Reports
Q3'26
Est.
$-0.21
Q2'26
Est.
$-0.19
Q1'26
Est.
$-0.19
Q4'25
Est.
$-0.17
Q3'25
Est.
$-0.17
The last earnings report on August 10 showed earnings per share of -18 cents, meeting the estimate of -18 cents. With 124.16K shares outstanding, the current market capitalization sits at 448.66M.
A.I. Advisor
published General Information

General Information

a developer of novel therapeutic compounds for diabetes and other diseases

Industry Biotechnology

Industry
Biotechnology
Address
301 Carlson Parkway
Phone
+1 763 496-5454
Employees
35
Web
https://www.diamedica.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RMNI4.260.10
+2.40%
Rimini Street
SAH60.350.50
+0.84%
Sonic Automotive
CHYM26.640.12
+0.45%
Chime Financial Inc
STI6.45-0.22
-3.37%
Solidion Technology Inc.
COLAU8.83-1.32
-13.00%
Columbus Acquisition Corp

DMAC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, DMAC has been loosely correlated with VIR. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if DMAC jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DMAC
1D Price
Change %
DMAC100%
+0.85%
VIR - DMAC
43%
Loosely correlated
+4.98%
EDIT - DMAC
42%
Loosely correlated
-0.77%
ANNX - DMAC
42%
Loosely correlated
+2.42%
SLDB - DMAC
39%
Loosely correlated
+0.98%
PRME - DMAC
38%
Loosely correlated
-1.13%
More
DiaMedica Therapeutics (DMAC) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com